Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
ERC and Horizon Europe
The European Union supports scientific excellence through several funding mechanisms, including grants from the European Research Council (ERC) and the Horizon Europe framework program.
ERC grants are among the most prestigious sources of funding in the world for basic and translational research. They enable researchers to pursue innovative projects through various programs designed for early-career researchers (Starting Grants), mid-career researchers (Consolidator Grants), and established researchers (Advanced Grants), as well as collaborative projects (Synergy Grants).
Key Figures
-
8
projects funded by the European Research Council (ERC), including 3 Starting Grants, 2 Consolidator Grants, 1 Advanced Grant, and 2 Synergy Grants.
-
3
Horizon Europe projects coordinated by Gustave Roussy
ERC Grants
ERC grants are among the most prestigious sources of funding in the world for basic and translational research. They enable researchers to pursue innovative projects through various programs designed for early-career researchers (Starting Grants), mid-career researchers (Consolidator Grants), and established researchers (Advanced Grants), as well as collaborative projects (Synergy Grants).
ERC Starting Grants
| Project | Principal Investigator | Objective |
| CHIC | Elsa Bernard |
To better understand the biological mechanisms involved in the development and progression of cancers, with the goal of identifying new diagnostic and therapeutic approaches. More information on the CHIC project: |
| TARGETSWITCH | Dr. Sophie Postel-Vinay |
Study of mechanisms of resistance to cancer treatments and the identification of new vulnerabilities that can be exploited for therapeutic purposes More information on TARGETSWITCH: |
| TheranoImmuno Sub-NK | Alexandre Detappe |
Exploration of new approaches combining imaging, therapeutic targeting, and immunotherapy to improve the effectiveness of cancer treatments
|
ERC Consolidator Grants
| Project | Principal Investigator | Objective |
| REGEM | Nataliya Petryk |
To better understand the mechanisms of genome replication and epigenetic information transmission, two processes that are essential in the onset and progression of cancers. More information on REGEM:
|
| CANPLAST | Luc Friboulet |
A project focused on tumor plasticity and the mechanisms by which cancer cells adapt to targeted therapies—a major challenge in the fight against drug resistance. More information on CANPLAST: |
ERC Advanced Grant
| Project | Principal Investigator | Objective |
| MADCAM | Prof. Laurence Zitvogel |
To study the interactions between the immune system, the microbiome, and cancers in order to develop new immunotherapy strategies. More information on MADCAM: |
ERC Synergy Grants
| Project | Principal Investigator | Objective |
| TREATLIVMETS |
Prof. Florent Ginhoux and Prof. Eric Vivier Collaborative project with the University of Strasbourg, the CNRS, Inserm, the Gustave Roussy Foundation, and Aix-Marseille University |
To better understand the immune microenvironment of liver metastases and develop innovative therapeutic approaches to improve their management. More information on TREATLIVEMETS: |
Horizon Europe Projects
Horizon Europe funds large-scale collaborative research projects involving multiple European partners to accelerate the development of new knowledge and innovations for the benefit of society.
| Project | Principal Investigator | Coordinator | Objective |
| OASIS | Dr. Barbara Pistilli | Gustave Roussy |
To improve personalized care for cancer patients through innovative approaches to clinical and translational research. Information and news about the Oasis project: |
| CARE1 | Prof. Laurence Albiges | Gustave Roussy |
Optimizing treatment strategies and the organization of care through a multidisciplinary, patient-centered approach Information and news about CARE1:
|
| PREVALUNG EU | Prof. Laurence Zitvogel | Gustave Roussy |
European program dedicated to the prevention, screening, and understanding of factors influencing lung cancer risk Information and news about Prevalung EU: Learn more:
|